Celltrion
068270.KS
£86.08
Share price
1.32%
Change (1 day)
-13.67%
Change (1 year)
Categories
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.
Revenue for Celltrion (068270.KS)
Revenue in 2024 (TTM): £2.01 Billion
According to Celltrion
's latest financial reports the company's current revenue (TTM 
) is £1.94 Billion. an increase over the revenue in the year 2023 that were of £1.29 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Celltrion from 2008 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | £2.05 B | 58.74% |
| 2023 | £1.29 B | -10.65% |
| 2022 | £1.44 B | 18.82% |
| 2021 | £1.21 B | 4.47% |
| 2020 | £1.16 B | 57.88% |
| 2019 | £0.73 B | 5.14% |
| 2018 | £0.70 B | 11.75% |
| 2017 | £0.62 B | 33.53% |
| 2016 | £0.47 B | 33.41% |
| 2015 | £0.35 B | 22.43% |
| 2014 | £0.28 B | 130.02% |
| 2013 | £0.12 B | -36.85% |
| 2012 | £0.19 B | |
| 2010 | £0.10 B | 41.1% |
| 2009 | £72 M | 46.6% |
| 2008 | £49.11 M |